Vatnak Vat-Ho
CIK: 0002160022
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKTX
Akari Therapeutics Plc
Officer
Discretionary Trading P&L
Holdings
About Vat-Ho Vatnak
Vat-Ho Vatnak (SEC CIK 0002160022) files insider reports with the SEC as Chief Business Officer of Akari Therapeutics Plc (AKTX).
Signal8 holds 2 ownership filings by Vat-Ho Vatnak (1 Form 3, 1 Form 4), filed on Oct 14, 2026. Those filings report 1 transaction, the latest on Oct 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vat-Ho Vatnak's filings is in TAMPA, FL.
Recent filings by Vat-Ho Vatnak
- Oct 12, 2026: Grant or award of AKTX derivative securities (Form 4, code A).
Other insiders filing for Akari Therapeutics Plc (AKTX)
- Prudo-Chlebosz Raymond, Director
- Huh Hoyoung, Director
- Patel Sandip I, Director
- Bazemore Robert B, Director
- Gaslightwala Abizer, CEO
- Patel Samir Rashmikant, Director